KTOV - 1.35 Pre-market now at 1.43/1.44 Kitov Announces Results of Study Demonstrating NT-219 Enhanced Efficacy of Keytruda® in Immune-Oncology Preclinical Model http://stockcharts.com/c-sc/sc?s=KTOV&p=D&b=5&g=0&i=t60757605188&r=1500383049015 http://stockcharts.com/c-sc/sc?s=KTOV&p=W&b=5&g=0&i=t93960699755&r=1500383067104